Fresenius SE & Co. (OTCMKTS:FSNUY) Shares Gap Up – Here’s What Happened

Fresenius SE & Co. (OTCMKTS:FSNUY)’s share price gapped up before the market opened on Friday . The stock had previously closed at $15.33, but opened at $15.94. Fresenius SE & Co. shares last traded at $15.38, with a volume of 2,671 shares traded.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on FSNUY. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Fresenius SE & Co. in a research note on Monday, October 27th. Finally, Citigroup reiterated a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, Fresenius SE & Co. has a consensus rating of “Buy”.

Fresenius SE & Co. Stock Performance

The stock’s 50-day simple moving average is $14.46 and its 200-day simple moving average is $14.30. The stock has a market cap of $34.43 billion, a price-to-earnings ratio of 27.78 and a beta of 0.75. The company has a current ratio of 1.26, a quick ratio of 0.99 and a debt-to-equity ratio of 0.49.

Fresenius SE & Co. Company Profile

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.